PNPLA3 and metabolic dysfunction-associated steatohepatitis: With higher prevalence of NASH recurrences in liver recipients who received the homozygous I148M allele, this suggests that PNPLA3 exerts its core physiological function primarily in the liver (Miyaaki et al., 2018).